The financing was co-led by new investor Dimension and existing investor OrbiMed. Additional investors included Amplitude Ventures, FSTQ, Lumira, Investissement Quebec, BDC Capita ...

Congruence Therapeutics是一家加拿大罕见病稳定剂药物研发商，致力于罕见病药物的研究与开发，旨在治疗法布里病等遗传疾病。Revenir是其专有的计算平台，利用数学建模、物理学和机器学习，来表征导致疾病的错误折叠蛋白的生物物理缺陷，然后设计化合物，通过 ...

Congruence Therapeutics是一家加拿大罕见病稳定剂药物研发商，致力于罕见病药物的研究与开发，旨在治疗法布里病等遗传疾病。Revenir是其专有的计算平台，利用数学建模、物理学和机器学习，来表征导致疾病的错误折叠蛋白的生物物理缺陷，然后设计化合物，通过计算机模拟校正这些缺陷以恢复突变蛋白功能，规避了（传统药物发现的）靶标验证、蛋白纯化、高通量筛选和苗头化合物分流（hit tria ...

Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in Neurology and Immunology Congruence to receive ...

The investment will fund the Phase I/Ib study of CGX-926 for MC4R-deficient genetic obesity in healthy subjects and patients.

The most dangerous leaders I've encountered aren't the obviously incompetent ones. They're the ones who say all the right things while something underneath feels fundamentally off. Their teams ...

To understand how an organization functions, you must analyze its dynamics and performance. The benefit of using a congruence model for this analysis is that it divides the analysis into four parts ...

The congruence model for a business is a change management process that examines the performance of an organization based on how it operates as a system. It was developped in the 1980s by ...

We've all known teachers who have left us with lasting memories and made us love their subject. On the other hand, we have sometimes experienced long hours of boredom listening to the "teacher" in the ...